First Time Loading...

Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 512.5 JPY 1.41% Market Closed
Updated: Apr 30, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

302.1B
+2%
Revenue
Growth Rates:
1 Year
+12%
3 Years
+25%
5 Years
+32%
7 Years
+54%
10 Years
+116%
49B
+14%
Operating Income
Growth Rates:
1 Year
-
3 Years
+56%
5 Years
+16%
7 Years
+47%
10 Years
+77%
27.7B
+5%
Net Income
Growth Rates:
1 Year
-
3 Years
+14%
5 Years
-11%
7 Years
+34%
10 Years
+56%

Earnings Waterfall
Santen Pharmaceutical Co Ltd

Revenue
302.1B JPY
Cost of Revenue
-119.1B JPY
Gross Profit
183B JPY
Operating Expenses
-134B JPY
Operating Income
49B JPY
Other Expenses
-21.3B JPY
Net Income
27.7B JPY

Income Statement
Santen Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
139 587
N/A
148 663
+7%
145 633
-2%
148 917
+2%
154 116
+3%
161 831
+5%
176 119
+9%
187 784
+7%
194 233
+3%
195 291
+1%
197 322
+1%
195 247
-1%
196 754
+1%
199 096
+1%
205 039
+3%
212 042
+3%
217 021
+2%
224 942
+4%
225 476
+0%
228 511
+1%
229 560
+0%
234 026
+2%
236 679
+1%
238 457
+1%
243 142
+2%
241 555
-1%
239 982
-1%
241 685
+1%
241 015
0%
249 605
+4%
257 028
+3%
259 459
+1%
263 620
+2%
266 257
+1%
266 804
+0%
266 413
0%
270 242
+1%
279 037
+3%
285 893
+2%
295 928
+4%
302 084
+2%
Gross Profit
Cost of Revenue
(54 317)
(58 104)
(57 440)
(56 780)
(56 212)
(56 373)
(60 654)
(66 287)
(71 674)
(72 829)
(73 355)
(73 164)
(73 731)
(74 966)
(78 152)
(81 101)
(83 483)
(86 378)
(87 819)
(89 179)
(90 042)
(90 764)
(91 862)
(93 294)
(95 307)
(94 831)
(95 452)
(96 234)
(96 371)
(98 221)
(100 404)
(101 383)
(105 028)
(109 671)
(111 153)
(112 706)
(112 417)
(112 950)
(114 569)
(116 504)
(119 101)
Gross Profit
85 270
N/A
90 559
+6%
88 193
-3%
92 137
+4%
97 904
+6%
105 458
+8%
115 465
+9%
121 497
+5%
122 559
+1%
122 462
0%
123 967
+1%
122 083
-2%
123 023
+1%
124 130
+1%
126 887
+2%
130 941
+3%
133 538
+2%
138 564
+4%
137 657
-1%
139 332
+1%
139 518
+0%
143 262
+3%
144 817
+1%
145 163
+0%
147 835
+2%
146 724
-1%
144 530
-1%
145 451
+1%
144 644
-1%
151 384
+5%
156 624
+3%
158 076
+1%
158 592
+0%
156 586
-1%
155 651
-1%
153 707
-1%
157 825
+3%
166 087
+5%
171 324
+3%
179 424
+5%
182 983
+2%
Operating Income
Operating Expenses
(57 613)
(63 245)
(60 209)
(61 541)
(64 699)
(70 084)
(75 177)
(34 973)
(38 757)
(42 282)
(43 775)
(88 501)
(89 776)
(91 651)
(93 163)
(96 210)
(98 460)
(99 762)
(101 006)
(100 855)
(97 257)
(101 872)
(100 489)
(101 878)
(107 451)
(106 864)
(112 224)
(112 241)
(113 146)
(113 828)
(143 297)
(145 769)
(146 929)
(120 609)
(120 587)
(155 647)
(158 466)
(130 787)
(169 997)
(136 560)
(133 962)
Selling, General & Administrative
(48 487)
(44 104)
(38 166)
(35 207)
(37 213)
(48 074)
(52 030)
(54 617)
(57 416)
(58 382)
(60 194)
(60 557)
(60 922)
(62 193)
(63 149)
(65 131)
(67 114)
(68 788)
(69 905)
(70 586)
(70 507)
(71 273)
(71 146)
(71 220)
(72 884)
(73 360)
(72 864)
(73 180)
(73 346)
(79 554)
(84 450)
(85 964)
(87 056)
(84 499)
(83 479)
(87 142)
(89 677)
(96 257)
(97 895)
(97 135)
(95 504)
Research & Development
(9 040)
(19 040)
(8 491)
(12 590)
(12 466)
(17 477)
(17 993)
(18 550)
(19 294)
0
(20 560)
(21 050)
(21 636)
(22 786)
(23 241)
(24 224)
(24 752)
(24 398)
(24 405)
(23 621)
(23 595)
(23 759)
(24 315)
(24 208)
(23 821)
(23 341)
(22 783)
(23 052)
0
(24 112)
(18 087)
(18 798)
(25 262)
(26 377)
(27 355)
(28 305)
(29 256)
(28 297)
(27 499)
(26 490)
(24 822)
Depreciation & Amortization
(85)
(100)
(871)
(2 071)
(3 374)
(4 798)
(5 349)
(5 681)
(5 953)
(7 229)
(6 359)
(6 374)
(6 377)
(6 412)
(6 482)
(6 567)
(6 647)
(6 740)
(6 823)
(6 889)
(6 977)
(6 988)
(7 726)
(8 451)
(9 167)
(9 898)
(9 869)
(9 840)
(10 230)
(10 650)
(10 623)
(10 559)
(10 161)
(9 734)
(9 867)
(10 112)
(9 703)
(9 518)
(9 292)
(9 051)
(9 375)
Other Operating Expenses
(1)
(1)
(12 681)
(11 673)
(11 646)
265
195
43 875
43 906
23 329
43 338
(520)
(841)
(260)
(291)
(288)
53
164
127
241
3 822
148
2 698
2 001
(1 579)
(265)
(6 708)
(6 169)
(29 570)
488
(30 137)
(30 448)
(24 450)
1
114
(30 088)
(29 830)
3 285
(35 311)
(3 884)
(4 261)
Operating Income
27 657
N/A
27 314
-1%
27 984
+2%
30 596
+9%
33 205
+9%
35 374
+7%
40 288
+14%
86 524
+115%
83 802
-3%
80 180
-4%
80 192
+0%
33 582
-58%
33 247
-1%
32 479
-2%
33 724
+4%
34 731
+3%
35 078
+1%
38 802
+11%
36 651
-6%
38 477
+5%
42 261
+10%
41 390
-2%
44 328
+7%
43 285
-2%
40 384
-7%
39 860
-1%
32 306
-19%
33 210
+3%
31 498
-5%
37 556
+19%
13 327
-65%
12 307
-8%
11 663
-5%
35 977
+208%
35 064
-3%
(1 940)
N/A
(641)
+67%
35 300
N/A
1 327
-96%
42 864
+3 130%
49 021
+14%
Pre-Tax Income
Interest Income Expense
1 201
994
167
438
(287)
489
843
134
215
(665)
(1 695)
(2 567)
(4 317)
(2 406)
(1 840)
(871)
597
747
(16)
(110)
(134)
(519)
(1 663)
(1 549)
(706)
270
(856)
(1 172)
(1 769)
(499)
(827)
(578)
(901)
(1 750)
457
61
(1 008)
(2 415)
(3 331)
(3 651)
(3 861)
Non-Reccuring Items
(884)
(1 477)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(111)
0
0
0
2 250
0
0
0
(7 474)
0
0
0
(25 361)
0
0
0
1 390
0
0
0
(38 688)
0
(1 833)
(5 806)
Gain/Loss on Disposition of Assets
(33)
(27)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
245
89
(47)
(116)
(122)
0
0
1
0
(45)
(1)
0
(1)
(18)
0
0
1
(177)
0
(1)
(1)
(4)
(2)
0
(2)
(565)
0
(2)
0
(8)
0
(1)
0
(1)
0
0
(1)
4
0
0
0
Pre-Tax Income
28 186
N/A
26 893
-5%
28 104
+5%
30 918
+10%
32 796
+6%
35 863
+9%
41 131
+15%
86 659
+111%
84 017
-3%
79 470
-5%
78 496
-1%
31 015
-60%
28 929
-7%
30 055
+4%
31 884
+6%
33 860
+6%
35 676
+5%
39 261
+10%
36 635
-7%
38 366
+5%
42 126
+10%
43 117
+2%
42 663
-1%
41 734
-2%
39 676
-5%
32 091
-19%
31 448
-2%
32 036
+2%
29 727
-7%
11 688
-61%
12 500
+7%
11 728
-6%
10 761
-8%
35 616
+231%
35 519
0%
(1 879)
N/A
(1 650)
+12%
(5 799)
-251%
(2 005)
+65%
37 378
N/A
39 353
+5%
Net Income
Tax Provision
(10 425)
(9 783)
(9 883)
(10 436)
(11 190)
(11 831)
(13 622)
(28 729)
(27 362)
(26 097)
(25 342)
(8 793)
(8 280)
(8 331)
(8 471)
(9 396)
(3 767)
(4 000)
(3 534)
(3 974)
(10 845)
(11 174)
(11 182)
(11 039)
(10 823)
(10 377)
(10 000)
(9 753)
(7 464)
(2 562)
(2 172)
(2 046)
(3 166)
(8 427)
(8 961)
(7 205)
(6 545)
(9 184)
(9 261)
(11 067)
(11 668)
Income from Continuing Operations
17 761
17 110
18 221
20 482
21 606
24 032
27 509
57 930
56 655
53 373
53 154
22 222
20 649
21 724
23 413
24 464
31 909
35 261
33 101
34 392
31 281
31 943
31 481
30 695
28 853
21 714
21 448
22 283
22 263
9 126
10 328
9 682
7 595
27 189
26 558
(9 084)
(8 195)
(14 983)
(11 266)
26 311
27 685
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
1
7
12
18
(9)
(14)
(16)
(21)
9
11
17
28
26
1 904
1 960
1 998
2 052
185
135
123
67
29
(18)
(46)
0
35
69
63
44
Net Income (Common)
17 760
N/A
17 109
-4%
18 221
+6%
20 483
+12%
21 605
+5%
24 032
+11%
27 508
+14%
57 930
+111%
56 656
-2%
53 373
-6%
53 155
0%
22 221
-58%
20 650
-7%
21 731
+5%
23 426
+8%
24 483
+5%
31 899
+30%
35 247
+10%
33 083
-6%
34 370
+4%
31 290
-9%
31 954
+2%
31 498
-1%
30 723
-2%
28 877
-6%
23 618
-18%
23 406
-1%
24 279
+4%
24 312
+0%
9 307
-62%
10 458
+12%
9 799
-6%
7 655
-22%
27 212
+255%
26 531
-3%
(9 138)
N/A
(8 203)
+10%
(14 955)
-82%
(11 205)
+25%
26 365
N/A
27 720
+5%
EPS (Diluted)
42.89
N/A
41.33
-4%
44
+6%
49.11
+12%
52.05
+6%
57.93
+11%
66.28
+14%
139.25
+110%
136.19
-2%
128.41
-6%
127.77
0%
53.54
-58%
50.48
-6%
52.76
+5%
57.41
+9%
60.02
+5%
78.18
+30%
86.42
+11%
81.09
-6%
84.23
+4%
76.63
-9%
78.44
+2%
78.7
+0%
76.74
-2%
72.12
-6%
59.01
-18%
58.48
-1%
60.65
+4%
60.7
+0%
23.26
-62%
26.11
+12%
24.46
-6%
19.11
-22%
67.97
+256%
66.77
-2%
-24.05
N/A
-21.22
+12%
-38.6
-82%
-29.96
+22%
72.91
N/A
78.1
+7%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.